Literature DB >> 22584506

Inhibition of RhoA/ROCK signaling pathway promotes the apoptosis of gastric cancer cells.

Xiao-Tao Xu1, Qi-Bin Song, Yi Yao, Peng Ruan, Ze-Zhang Tao.   

Abstract

BACKGROUND/AIMS: Ras homologue A (RhoA) plays a crucial role in the proliferation, apoptosis,adhesion and migration of gastric cancer cells. Rho associated kinase (ROCK) is an effector protein of RhoA.
METHODOLOGY: In the present study, RhoA activity was inhibited by siRNA targeting RhoA andY-27632, an inhibitor of ROCK, and the role of RhoA/ROCK signaling pathway in the apoptosis of gastric cancer cells was investigated.
RESULTS: RNAi of RhoA inhibited the survival and promoted the apoptotic of AGS cells. RhoA RNAi caused an obvious decrease of ROCK1 expression but an increase of caspase-3/cleaved-caspase-8. Inhibition of ROCK by Y-27632 inhibited the activity of RhoA and promoted the apoptosis.
CONCLUSIONS: We speculate that RhoA/ROCK signaling pathway plays an important role in the regulation of apoptosis of gastric cancer, and to inhibit this pathway may promote the apoptosis of cancer cells. Thus, inhibition of RhoA/ROCK signaling pathway may become a novel target in the treatment of gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22584506     DOI: 10.5754/hge12147

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  16 in total

1.  Effects of isoprenylcysteine carboxyl methyltransferase silencing on the proliferation and apoptosis of tongue squamous cell carcinoma.

Authors:  Shao-Ru Wang; Wei Sun; Nan Zhou; Kai Zhao; Wen-Jian Li; Zeng-Peng Chi; Ying Wang; Qi-Min Wang; Lei Tong; Zong-Xuan He; Hong-Yu Han; Zheng-Gang Chen
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2021-02-01

2.  The role of RhoA in vulvar squamous cell carcinoma: a carcinogenesis, progression, and target therapy marker.

Authors:  Jing Wang; Qiong Wu; Li-Hua Zhang; Yun-Xia Zhao; Xin Wu
Journal:  Tumour Biol       Date:  2015-09-26

3.  ROCK inhibitor Y-27632 inhibits the growth, migration, and invasion of Tca8113 and CAL-27 cells in tongue squamous cell carcinoma.

Authors:  Zhi-Ming Wang; Dong-Sheng Yang; Jie Liu; Hong-Bo Liu; Ming Ye; Yu-Fei Zhang
Journal:  Tumour Biol       Date:  2015-10-14

4.  Inhibition of Rho-associated coiled-coil-forming kinase increases efficacy of measles virotherapy.

Authors:  M Opyrchal; C Allen; P Msaouel; I Iankov; E Galanis
Journal:  Cancer Gene Ther       Date:  2013-10-25       Impact factor: 5.987

5.  Low RhoA expression is associated with adverse outcome in melanoma patients: a clinicopathological analysis.

Authors:  Maciej Kaczorowski; Przemyslaw Biecek; Piotr Donizy; Malgorzata Pieniazek; Rafal Matkowski; Agnieszka Halon
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

Review 6.  RhoA/mDia-1/profilin-1 signaling targets microvascular endothelial dysfunction in diabetic retinopathy.

Authors:  Qianyi Lu; Li Lu; Wei Chen; Haibing Chen; Xun Xu; Zhi Zheng
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-03-20       Impact factor: 3.117

Review 7.  Rho/ROCK signaling in motility and metastasis of gastric cancer.

Authors:  Tasuku Matsuoka; Masakazu Yashiro
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

8.  A protein and mRNA expression-based classification of gastric cancer.

Authors:  Namrata Setia; Agoston T Agoston; Hye S Han; John T Mullen; Dan G Duda; Jeffrey W Clark; Vikram Deshpande; Mari Mino-Kenudson; Amitabh Srivastava; Jochen K Lennerz; Theodore S Hong; Eunice L Kwak; Gregory Y Lauwers
Journal:  Mod Pathol       Date:  2016-04-01       Impact factor: 7.842

9.  miR-340 suppresses glioblastoma multiforme.

Authors:  Daquan Huang; Shuwei Qiu; Ruiguang Ge; Lei He; Mei Li; Yi Li; Ying Peng
Journal:  Oncotarget       Date:  2015-04-20

10.  Effects of Artificial Ligaments with Different Porous Structures on the Migration of BMSCs.

Authors:  Chun-Hui Wang; Wei Hou; Ming Yan; Zhong-Shang Guo; Qi Wu; Long Bi; Yi-Sheng Han
Journal:  Stem Cells Int       Date:  2015-05-28       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.